极减活麻疹病毒疫苗（CAM-EX）的研发 - Suppr

Suppr

超能文献

Development of extremely attenuated live measles virus vaccine (CAM-EX).

作者信息

Ueda S, Takahashi M, Kurimura T, Minekawa Y, Suzuki N

出版信息

Biken J. 1972 Sep;15(3):173-7.

PMID:4643692

Abstract

摘要

相似文献

Development of extremely attenuated live measles virus vaccine (CAM-EX).极减活麻疹病毒疫苗（CAM-EX）的研发

Biken J. 1972 Sep;15(3):173-7.

Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.进一步减毒活麻疹疫苗的研究。3. 选择CAM麻疹疫苗病毒反应性较低的变异株。

Biken J. 1970 Sep;13(3):163-8.

Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.进一步减毒活麻疹疫苗的研究。IV. CAM-CEF麻疹疫苗病毒克隆株的临床和血清学评价。

Biken J. 1970 Sep;13(3):169-74.

Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.泰国麻疹研究。六、“CAM 70”麻疹病毒疫苗在居家儿童中的临床试验。

Biken J. 1973 Dec;16(4):167-71.

Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.

Biken J. 1974 Mar;17(1):11-20.

Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.

Biken J. 1970 Sep;13(3):175-8.

An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.一种极度减毒的麻疹活病毒疫苗（CAM-EX）。患有精神运动发育迟缓的机构收容儿童接种疫苗后低滴度抗体的持续存在情况。

Biken J. 1981 Sep;24(3):119-22.

Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.进一步减毒活麻疹疫苗的研究。VII. CAM-70麻疹病毒疫苗的研制与评价。

Biken J. 1971 Sep;14(3):253-8.

Comparative study on two further attenuated live measles virus vaccines, "CAM" and "Moraten".两种进一步减毒活麻疹病毒疫苗“CAM”和“莫拉坦”的对比研究。

Biken J. 1971 Mar;14(1):77-9.

The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.罗马尼亚麻疹的特异性预防。人二倍体细胞制备疫苗的研究。

Rev Roum Virol (1972). 1973;10(1):8-17.

引用本文的文献

Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.爱泼斯坦-巴尔病毒转化的狨猴B细胞系B95a细胞上膜辅因子蛋白（MCP；CD46）的分子克隆：B95a-MCP对CAM株敏感，但对麻疹病毒长畑株不敏感。

Biochem J. 1998 Mar 15;330 ( Pt 3)(Pt 3):1351-9. doi: 10.1042/bj3301351.

Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46).用补体膜辅因子蛋白（CD46）的重组可溶性形式或针对其的单克隆抗体阻断麻疹病毒感染。

Immunology. 1995 Apr;84(4):619-25.

Structural defect linked to nonrandom mutations in the matrix gene of biken strain subacute sclerosing panencephalitis virus defined by cDNA cloning and expression of chimeric genes.通过cDNA克隆和嵌合基因表达确定的与比肯株亚急性硬化性全脑炎病毒基质基因非随机突变相关的结构缺陷。

J Virol. 1989 Mar;63(3):1162-73. doi: 10.1128/JVI.63.3.1162-1173.1989.

Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus.偏向性高突变在亚急性硬化性全脑炎病毒从原始急性麻疹病毒进化过程中的作用。

J Virol. 1991 May;65(5):2191-9. doi: 10.1128/JVI.65.5.2191-2199.1991.

Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence.亚急性硬化性全脑炎病毒在混合感染中主要干扰野生型麻疹病毒的复制：对病毒持续性的影响

J Virol. 1992 Apr;66(4):1891-8. doi: 10.1128/JVI.66.4.1891-1898.1992.

The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different.神经毒性亚急性硬化性全脑炎病毒及其急性麻疹病毒前身的基质蛋白在功能上有所不同。

Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8745-9. doi: 10.1073/pnas.89.18.8745.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验